2. Schrodinger $85M
Round: Series E
Description: Schrodinger is involved in computational drug designing for pharmaceutical and biotechnology research.
Industry: Biotechnology, Enterprise Software, Pharmaceutical, Software
Total equity funding raised: $137M
Full exclusive coverage on Alleywatch: Schrodinger’s Series E round
The AlleyWatch audience is driving progress and innovation at a global scale. With its regional media properties, AlleyWatch serves as the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including sponsoring a piece like this, which will be read by the vast majority of key influencers in the entrepreneurial universe. Find out more here.